Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers across the UK and Europe.
This collaboration integrates Stratipath’s technology with Diagnexia’s digital pathology network, providing faster, more precise cancer diagnostics. The partnership aims to improve decision-making for breast cancer treatments.